CorMedix Inc.
NASDAQCorMedix reports its next earnings event on August 13, and the setup is defined by one uncomfortable tension: short sellers have built a substantial position in a stock down 16% over the past month, yet options traders remain notably relaxed heading into the print. Short interest at nearly 20% of free float is the dominant feature of this story. At 19.5% of free float — up 7.4%…
CRMD SI utilization surges to 97.1%, near 52-week peak of 100%, as borrowing demand intensifies despite 8% monthly decline in short interest.
CorMedix reports its next earnings event on August 13, and the setup is defined by one uncomfortable tension: short sellers have built a substantial position in a stock down 16% over the past month, yet options traders…
CorMedix heads into July with a stubborn short base, a stock down nearly 9% on the week, and an August earnings date that is moving from background noise to front-of-mind. The short side of the ledger is the defining…
Snapshot as of 16 Aug 2026
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CRMD — free to start on ORTEX.
Sign up for free →Open CRMD on ORTEX